Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blue mussel lipid extract is a lipid-rich supplement or nutraceutical derived from the tissue of the blue mussel (*Mytilus edulis*), containing a complex mixture of polyunsaturated fatty acids (notably EPA and DHA), neutral lipids, polar lipids, and minor components such as sterols and ceramides. Extracted typically via solvent methods (including chloroform/methanol or ethyl acetate), this product is studied and sometimes marketed for its **anti-inflammatory effects** in conditions like rheumatoid arthritis and type 2 diabetes mellitus, as well as for its potential to improve lipid profiles and reduce inflammatory cytokines. Its effects are believed to result from a combination of classic marine omega-3 fatty acids and unique lipid species, some of which may exhibit direct biological activity such as cyclooxygenase inhibition and immune regulation[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on blue mussel lipid extract.